Patients under going MIS TLIF one level
Conditions
Interventions
The drugs in multimodal group consist of 0.5% bupivacaine 92.5 mg (18.5ml.) Ketorolac 30mg (1ml.) Morphine 5mg (0.5ml.) & adrenaline 0.5mg (0.5ml)
10 ml. into facet joint before incision
10 ml. Into s
subcutaneous & thoracolumbar fascia at the end of operation
,The drugs in control group consist of 0.5% bupivacaine 100 mg (20ml.) & adrenaline 0.5mg (0.5ml)
10 ml. into facet joint before incision
10
subcutaneous & thoracolumbar fascia at the end of operation
Experimental Drug,Experimental Drug
Multimudal group,Control group
Sponsors
Chulalongkorn University
Eligibility
Sex/Gender
All
Age
20 Years to 80 Years
Inclusion criteria
Inclusion criteria: Pt. under going MIS TLIF 1 level Age 20-80 years Good mental status Complete inform & consent
Exclusion criteria
Exclusion criteria: Allergy or contraindication to any drugs in this study Impair renal and/or hepatic function Other comorbid pain condition
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Post-operative Pain score at 3, 6, 12, 24 hrs 3, 6, 12, 24 hrs post-operation Visual analog scale | — |
Secondary
| Measure | Time frame |
|---|---|
| Post-operative morphine consumption 24 hrs post-operatively Observe among of morphine that patient required,Blood loss in close suction drain until drain is removed Observe in close suction drain,Morphine related side effect 24 hrs post-operatively Patient reported,Time to ambulation Post-operative until ambulation Observe when patient start to ambulation with/without walker,Length of hospital stay Post-operative until discharge Medical record | — |
Countries
Thailand
Contacts
Public ContactTodsapon Chancharoenchai
Orthopedics department, Faculty of medicine, Chulalongkorn university
Outcome results
None listed